Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Clinical Specificity of the Active Anthrax Detect™ Plus (AAD Plus) Lateral Flow Immunoassay (LFI)

NCT04320485 is registered in ClinicalTrials.gov with InBios International, Inc. as lead sponsor.

NCT NCT04320485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04320485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Clinical Specificity of the Active Anthrax Detect™ Plus (AAD Plus) Lateral Flow Immunoassay (LFI)
Lead sponsor
InBios International, Inc.
Phase
Observational
Overall status
Completed
Start date
March 25, 2020
Completion date
December 17, 2020
Enrollment
450 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anthrax